S-Ventures PLC - The VSA Capital, Aquis Showcase Event
RNS Number : 7468G
S-Ventures PLC
17 November 2022
 

17 November 2022

S-VENTURES PLC

("S-Ventures" or the "Company")

The VSA Capital, Aquis Showcase Event

S-Ventures, the company investing in and growing exciting brands across the natural, wellness and food-tech category, is pleased to announce that the Company will be presenting at The VSA Capital, Aquis Showcase Event on 29 November 2022 at the Royal College of Surgeons of England, 38-43 Lincoln's Inn Fields, London, WC2A 3PE. The Company is looking forward to meeting existing and future shareholders at the event.

 

20 companies will be presenting during the course of the day and will be split into 4 groups and given 10 minutes each to pitch their business case to the audience, who will vote for their favourites using a QR code. The Company will give a presentation between 12:00-12:45 on 29 November.

For further information on The VSA Capital Aquis Showcase Event and to register for tickets, please visit The VSA Capital, Aquis Showcase Event Tickets, Tue 29 Nov 2022 at 08:00 | Eventbrite

For further information, please contact:

The Company

Robert Hewitt (Chief Financial Officer)

Scott Livingston (Chief Executive Officer)

+44 (0) 1932 400 224



AQSE Corporate Adviser and Broker:

VSA Capital Limited

Andrew Raca - Corporate Finance

Andrew Monk - Corporate Broking

+44 (0) 20 3005 5000



IFC Advisory (Financial PR)

Graham Herring

Tim Metcalfe

Florence Chandler

+44 (0) 20 3934 6630

 

About S-Ventures

S-Ventures is listed on UK AQUIS Exchange (Ticker Code "SVEN"). The Company seeks to identify investment opportunities in the health & wellness, organic food and wellbeing sectors within the UK and Europe, adding value by providing capital and expertise to the target companies. The experience and operational skills of the Board led by Scott Livingston (CEO) are intended to act as an accelerator to smaller brands that have a solid foundation and platform but may lack the skills and capital. The main objectives are to cross-fertilise opportunities between the target companies and scale the individual entities and look for exit opportunities and/or synergistic collaborations through scaling we seek to create significant value for all stakeholders. Since listing on AQSE in September 2020, the Company has acquired significant interests in seven companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXBKOBBABDKCDD ]]>